Potential strategies include developing antibodies or nanomedicines targeting secreted FABP5, investigating synergistic effects of FABP5 inhibitors with immune checkpoint inhibitors or chemotherapy, and using multi-omics approaches to dissect dynamic FABP5 regulatory networks in the tumor microenvironment. The gene discussed is FABP5; the disease is neoplasm.